![Quiver Logo](/static/img/logo-icon.png)
![HOOK logo](https://quiver-logos.s3.us-east-2.amazonaws.com/hook.png)
HOOKIPA Pharma Inc. Common Stock
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view HOOK Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of HOOK by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by HOOK's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to HOOK
Recent picks made for HOOK stock on CNBC
ETFs with the largest estimated holdings in HOOK
Flights by private jets registered to HOOK
![Quiver Logo](/static/img/logo-icon.png)